Effect of denosumab on Japanese patients with rheumatoid arthritis: A dose-response study of AMG 162 (Denosumab) in patients with rheumatoid arthritis on methotrexate to validate inhibitory effect on bone erosion (DRIVE) - A 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial

Tsutomu Takeuchi, Yoshiya Tanaka, Naoki Ishiguro, Hisashi Yamanaka, Toshiyuki Yoneda, Takeshi Ohira, Naoki Okubo, Harry K. Genant, Désirée Van Der Heijde

Research output: Contribution to journalArticlepeer-review

90 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effect of denosumab on Japanese patients with rheumatoid arthritis: A dose-response study of AMG 162 (Denosumab) in patients with rheumatoid arthritis on methotrexate to validate inhibitory effect on bone erosion (DRIVE) - A 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds